期刊文献+

人表皮生长因子受体3与消化系统恶性肿瘤患者预后关系的meta分析

下载PDF
导出
摘要 目的 评价人表皮生长因子受体3(HER3)表达与恶性消化系统肿瘤预后的相关性.方法 联网检索pubmed上研究HER3与消化系统恶性肿瘤患者预后关系的文章,应用Cochrane协作网提供的RevMan5.16版本软件进行meta分析.结果 纳入符合要求的文章6篇,总计776例患者.meta分析结果显示HER3阳性表达与HER3阴性表达3年及5年总生存率差异有显著性(3年生存率:OR值1.70,95%CI:1.17~2.49;5年生存率:OR值1.76,95%CI:1.24~2.51).亚组分析结果显示HER3表达与胃癌的预后存在相关性(OR值3.45,95%CI:2.01~5.95),但与大肠癌的预后不存在相关性(OR值0.53,95%CI:0.26~1.08).结论 HER3表达与消化系统恶性肿瘤的预后相关,对于恶性消化系统肿瘤尤其是胃癌患者的预后有判断价值.
出处 《中国医刊》 CAS 2014年第2期61-62,共2页 Chinese Journal of Medicine
  • 相关文献

参考文献14

  • 1方阳,张筱骅,夏建福.人表皮生长因子受体-2与拓扑异构酶Ⅱ在结直肠癌中的表达及意义[J].中国医刊,2012,47(10):59-61. 被引量:3
  • 2Kim JW,Im SA,Kim M. The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen[J].{H}Anticancer Research,2012,(04):1547-1553.
  • 3García I,Vizoso F,Martín A. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer[J].{H}ANNALS OF SURGICAL ONCOLOGY,2003,(03):234-241.
  • 4Baiocchi G,Lopes A,Coudry RA. ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery[J].{H}International Journal of Colorectal Disease,2009,(09):1059-1068.
  • 5Hayashi M,Inokuchi M,Takagi Y. High expression of HER3 is associated with a decreased survival in gastric cancer[J].{H}Clinical Cancer Research,2008,(23):7843-7849.
  • 6Kountourakis P,Pavlakis K,Psyrri A. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas[J].{H}BMC Cancer,2006,(01):46.
  • 7Beji A,Horst D,Engel J. Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer[J].{H}Clinical Cancer Research,2012,(04):956-968.
  • 8Hirakawa T,Nakata B,Amano R. HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer[J].{H}ONCOLOGY-BASEL,2011,(3-4):192-198.
  • 9Begnami MD,Fukuda E,Fregnani JH. Prognostic implications of altered human epidermal growth factor receptors(HERs) in gastric carcinomas:HER2 and HER3 are predictors of poor outcome[J].{H}Journal of Clinical Oncology,2011,(22):3030-3036.
  • 10Baselga J,Swain SM. Novel anticancer targets:revisiting ERBB2 and discovering ERBB3[J].{H}Nature Reviews Cancer,2009,(07):463-475.

二级参考文献14

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部